{
    "clinical_study": {
        "@rank": "149790", 
        "arm_group": [
            {
                "arm_group_label": "Nivolumab Monotherapy", 
                "arm_group_type": "Experimental", 
                "description": "Nivolumab administered as IV infusion at a dose of 3mg/kg every 2 weeks until disease progression"
            }, 
            {
                "arm_group_label": "Nivolumab + Ipilimumab", 
                "arm_group_type": "Experimental", 
                "description": "Dose Escalation Phase:\nDose Level -1: Nivolumab 0.3mg/Kg IV combined with Ipilimumab 1 mg/Kg IV every 3 weeks for 4 doses followed by Nivolumab 3mg/Kg IV every 2 weeks until disease progression\nDose Level 1: Nivolumab 1mg/Kg IV combined with Ipilimumab 1 mg/Kg IV every 3 weeks for 4 doses followed by Nivolumab 3mg/Kg IV every 2 weeks until disease progression\nDose Level 2a: Nivolumab 1mg/Kg IV combined with Ipilimumab 3 mg/Kg IV every 3 weeks for 4 doses followed by Nivolumab 3mg/Kg IV every 2 weeks until disease progression\nDose Level 2b: Nivolumab 3mg/Kg IV combined with Ipilimumab 1 mg/Kg IV every 3 weeks for 4 doses followed by Nivolumab 3mg/Kg IV every 2 weeks until disease progression"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine if Nivolumab alone or in combination with Ipilimumab\n      will demonstrate a meaningful objective response rate in patients with recurrent and\n      metastatic colon cancer who also have a specific biomarker in their tumors."
        }, 
        "brief_title": "A Study of Nivolumab and Nivolumab Plus Ipilimumab in Recurrent and Metastatic Colon Cancer (CheckMate 142)", 
        "completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "MSI Positive Colorectal Cancer", 
            "MSI Negative Colorectal Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Colonic Neoplasms", 
                "Colorectal Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Allocation: The Microsatellite Instability High (MSI-High) Part of the trial is\n      Non-randomized, The Non-MSI high part of the trial contains a randomized portion"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "For more information regarding BMS clinical trial participation, please visit\n        www.BMSStudyConnect.com\n\n        Inclusion Criteria:\n\n          -  Men and women \u2265 18 years of age\n\n          -  Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1\n\n          -  Histologically confirmed colorectal cancer\n\n          -  Measurable disease by CT or MRI\n\n          -  Testing for MSI Status\n\n          -  Adequate organ function as defined by study-specific laboratory tests\n\n          -  Must use acceptable form of birth control throughout the study. After the final dose\n             of study drug, an acceptable form of birth control must be used for 23 weeks for\n             women of childbearing potential (WOCBP) and 31 weeks for men who are sexually active\n             with WOCBP\n\n          -  Signed informed consent\n\n          -  Willing and able to comply with study procedures\n\n        Exclusion Criteria:\n\n          -  Active brain metastases or leptomeningeal metastases are not allowed.\n\n          -  Prior treatment with an anti-Programmed Death Receptor (PD)-1, anti-PD-L1,\n             anti-PD-L2, anti-Cytotoxic T-Cell Lymphoma-4 Antigen (CTLA-4) antibody, or any other\n             antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint\n             pathways\n\n          -  Prior malignancy active within the previous 3 years except for locally curable\n             cancers\n\n          -  Subjects with active, known or suspected autoimmune disease\n\n          -  Subjects with a condition requiring systemic treatment with either corticosteroids or\n             other immunosuppressive medications within 14 days of study drug administration"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "96", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02060188", 
            "org_study_id": "CA209-142", 
            "secondary_id": "2013-003939-30"
        }, 
        "intervention": [
            {
                "arm_group_label": "Nivolumab + Ipilimumab", 
                "intervention_name": "Ipilimumab", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Nivolumab Monotherapy", 
                    "Nivolumab + Ipilimumab"
                ], 
                "intervention_name": "Nivolumab", 
                "intervention_type": "Drug", 
                "other_name": "BMS-936558"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 30, 2014", 
        "link": [
            {
                "description": "BMS Clinical Trial Information", 
                "url": "http://ctr.bms.com/ctd/start.do"
            }, 
            {
                "description": "BMS clinical trial educational resource", 
                "url": "http://www.bms.com/studyconnect/Pages/home.aspx"
            }, 
            {
                "description": "Investigator Inquiry form", 
                "url": "http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"
            }, 
            {
                "description": "FDA Safety Alerts and Recalls", 
                "url": "http://www.fda.gov/MEDWATCH/safety.htm"
            }
        ], 
        "location": [
            {
                "contact": {
                    "last_name": "Site 0028"
                }, 
                "facility": {
                    "address": {
                        "city": "Gilbert", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85234"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0004"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ari Baron, Site 0001", 
                    "phone": "415-600-1775"
                }, 
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94115"
                    }, 
                    "name": "Pacific Hematology Oncology Associates"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0007"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33612"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Bassel El-Rayes, Site 0008", 
                    "phone": "404-778-1972"
                }, 
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30322"
                    }, 
                    "name": "Emory University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0002"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0036"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02215"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Joseph Leach, Site 0034", 
                    "phone": "612-863-5658"
                }, 
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55407"
                    }, 
                    "name": "Allina Health"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0009"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11065"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michael Morse, Site 0024"
                }, 
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Duke University Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0029"
                }, 
                "facility": {
                    "address": {
                        "city": "Winston Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27103"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Todd Crocenzi, Site 0005", 
                    "phone": "503-215-2492"
                }, 
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97213"
                    }, 
                    "name": "Providence Cancer Center Oncology And Hematology Care- Eastside"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0014"
                }, 
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0013"
                }, 
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15232"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0006"
                }, 
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37232"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michael Overman, Site 0003", 
                    "phone": "713-563-7757"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "The University Of Texas Md Anderson Cancer Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0027"
                }, 
                "facility": {
                    "address": {
                        "city": "Edmonton", 
                        "country": "Canada", 
                        "state": "Alberta", 
                        "zip": "T6G 1Z2"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0016"
                }, 
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 1X5"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0026"
                }, 
                "facility": {
                    "address": {
                        "city": "Montpellier Cedex 05", 
                        "country": "France", 
                        "zip": "34298"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0025"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75012"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0023"
                }, 
                "facility": {
                    "address": {
                        "city": "Dublin 9", 
                        "country": "Ireland", 
                        "state": "Dublin"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0022"
                }, 
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland", 
                        "zip": "DUBLIN4"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0033"
                }, 
                "facility": {
                    "address": {
                        "city": "Galway", 
                        "country": "Ireland"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0030"
                }, 
                "facility": {
                    "address": {
                        "city": "Candiolo", 
                        "country": "Italy", 
                        "state": "TO", 
                        "zip": "10060"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0035"
                }, 
                "facility": {
                    "address": {
                        "city": "Modena", 
                        "country": "Italy", 
                        "zip": "41124"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Site 0032"
                }, 
                "facility": {
                    "address": {
                        "city": "Padova", 
                        "country": "Italy", 
                        "zip": "Padova"
                    }, 
                    "name": "Local Institution"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada", 
                "France", 
                "Ireland", 
                "Italy"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 2 Clinical Trial of Nivolumab and Nivolumab Plus Ipilimumab in Recurrent and Metastatic Microsatellite High (MSI-H) Colon Cancer", 
        "overall_contact": {
            "email": "Clinical.Trials@bms.com", 
            "last_name": "Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:"
        }, 
        "overall_contact_backup": {
            "last_name": "First line of the email MUST contain NCT# and Site #."
        }, 
        "overall_official": {
            "affiliation": "Bristol-Myers Squibb", 
            "last_name": "Bristol-Myers Squibb", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Australia: Department of Health and Ageing Therapeutic Goods Administration", 
                "Australia: National Health and Medical Research Council", 
                "Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment", 
                "Canada: Health Canada", 
                "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
                "Ireland: Irish Medicines Board", 
                "Italy: Ministry of Health", 
                "Italy: National Bioethics Committee", 
                "Italy: National Institute of Health", 
                "Italy: National Monitoring Centre for Clinical Trials - Ministry of Health", 
                "Italy: The Italian Medicines Agency", 
                "Spain: Spanish Agency of Medicines"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "(Tumor imaging assessments will occur every 6 weeks from the date of first dose (+/-1 wk) for the first 24 weeks, then every 12 wks (+/- 1 wk) thereafter until disease progression or treatment is discontinued (whichever occurs later)) (Tumor imaging assessments will occur every 6 weeks from the date of first dose (+/-1 wk) for the first 24 weeks, then every 12 wks (+/- 1 wk) thereafter until disease progression or treatment is discontinued (whichever occurs later))", 
            "measure": "Objective response rate (ORR) in all MSI-High subjects as determined by Investigators", 
            "safety_issue": "No", 
            "time_frame": "The final analysis of the primary endpoint will occur at least 6 months after the last enrolled subject's first dose of study therapy (Approximately up to 34 months)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02060188"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Tumor imaging assessments will occur every 6 weeks from the date of first dose (+/- wk) for the first 24 weeks, then every 12 wks (+/- 1 wk) thereafter until disease progression or treatment is discontinued(whichever occurs later)", 
            "measure": "ORR in all MSI-H subjects based on IRRC determination", 
            "safety_issue": "No", 
            "time_frame": "The final analysis of the secondary endpoint will occur the time of the primary endpoint analysis (Approximately up to 34 months)"
        }, 
        "source": "Bristol-Myers Squibb", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}